Science

A CRISPR gene boost reduces seizures and strengthens muscles in mice

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 02/11/2026, 18:25:24 UTC.

Briefings

A new CRISPR delivery system developed by researchers at the Shanghai Institute of Materia Medica successfully treats genetic diseases in mice by delivering multiple genes simultaneously via a single viral package. This breakthrough addresses the difficulty of targeting several genes at once, offering a potential solution for conditions where cells lack essential proteins.

Key points

• Researchers at the Shanghai Institute of Materia Medica developed a compact CRISPR system using a single viral delivery package to treat multiple genes simultaneously.
• The system was tested in mice with genetic diseases, showing reduced seizures and improved muscle strength compared to previous methods.

Context

Genetic diseases often leave cells without crucial proteins, and traditional delivery methods struggle to target several genes at once. This study represents a significant advancement in gene therapy delivery technology.

Limitations

The evidence is limited to mouse models; human clinical trials are not yet conducted. Results may vary across different genetic conditions and species.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 02/11/2026, 20:07:22 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeihbyix4omjj4aglcbk53tcaknx6fryedrnxb63kv2k5p3xr4qehtq